FertilAI optimizes the fertility journey for healthcare providers and patients alike. Its mission is to bring advanced, clinically proven AI technology to enhance care. The FertilAI scientifically validated clinical decision-support platform enhances fertility treatment and contributes to improved outcomes. FertilAI provides a patient-focused mobile app that connects with clinics’ electronic medical record (EMR) platform focusing on improving patient communication. For more information, visit www.fertilai.com.
K2 provided comprehensive PR services.
| Femtech Insider | FertilAI Secures $4.5M to Scale AI-Driven Fertility Treatment Platform | Article | |
| Fortune | Company Mention | ||
| Healthtech World | Article | ||
| Tech in Asia | Article | ||
| Startups Magazine | Article | ||
| Phunu Vietnam | Article | ||
| Israel21C | Article | ||
| Femtech World | AI decision support platform launches in 10 US fertility clinics | Article | |
| Healthcare IT Today | AI decision support platform launches in 10 US fertility clinics | Company Mention |